OVERSEA CHINESE BANKING Corp Ltd Buys 3,840 Shares of Danaher Corporation $DHR

OVERSEA CHINESE BANKING Corp Ltd raised its stake in shares of Danaher Corporation (NYSE:DHR) by 9.3% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 45,022 shares of the conglomerate’s stock after acquiring an additional 3,840 shares during the quarter. OVERSEA CHINESE BANKING Corp Ltd’s holdings in Danaher were worth $8,922,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in the company. Norges Bank acquired a new position in Danaher in the second quarter valued at about $1,979,503,000. Viking Global Investors LP raised its stake in shares of Danaher by 543.9% in the second quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock valued at $574,351,000 after acquiring an additional 2,455,994 shares during the last quarter. Generation Investment Management LLP raised its stake in shares of Danaher by 56.2% in the second quarter. Generation Investment Management LLP now owns 4,965,646 shares of the conglomerate’s stock valued at $980,914,000 after acquiring an additional 1,787,522 shares during the last quarter. Primecap Management Co. CA boosted its holdings in shares of Danaher by 924.2% in the 2nd quarter. Primecap Management Co. CA now owns 1,239,320 shares of the conglomerate’s stock worth $244,815,000 after acquiring an additional 1,118,318 shares in the last quarter. Finally, Vanguard Group Inc. grew its position in Danaher by 1.3% during the 2nd quarter. Vanguard Group Inc. now owns 60,769,587 shares of the conglomerate’s stock worth $12,004,424,000 after acquiring an additional 788,499 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Insider Activity

In other Danaher news, SVP Georgeann Couchara sold 5,174 shares of the stock in a transaction on Monday, November 10th. The shares were sold at an average price of $210.42, for a total value of $1,088,713.08. Following the sale, the senior vice president directly owned 2,625 shares in the company, valued at approximately $552,352.50. This trade represents a 66.34% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Brian W. Ellis sold 21,776 shares of Danaher stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the transaction, the senior vice president directly owned 14,553 shares in the company, valued at approximately $3,190,454.19. This represents a 59.94% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 30,248 shares of company stock valued at $6,609,663 in the last ninety days. 11.10% of the stock is owned by insiders.

Danaher Trading Up 1.0%

Shares of NYSE DHR opened at $237.92 on Thursday. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $258.23. The firm has a market capitalization of $168.05 billion, a P/E ratio of 49.05, a P/E/G ratio of 4.19 and a beta of 0.89. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10. The company’s 50 day simple moving average is $227.21 and its 200 day simple moving average is $211.39.

Danaher (NYSE:DHR) last issued its earnings results on Monday, October 20th. The conglomerate reported $1.89 EPS for the quarter, beating the consensus estimate of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The company had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same quarter in the previous year, the company posted $1.71 EPS. The business’s revenue for the quarter was up 4.4% compared to the same quarter last year. On average, analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.5%. The ex-dividend date is Friday, December 26th. Danaher’s payout ratio is presently 26.39%.

Analyst Ratings Changes

A number of equities analysts have commented on DHR shares. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a research note on Saturday, November 22nd. Cowen reiterated a “buy” rating on shares of Danaher in a research report on Wednesday, January 7th. KeyCorp restated an “overweight” rating on shares of Danaher in a research report on Thursday, December 18th. The Goldman Sachs Group began coverage on shares of Danaher in a research report on Tuesday, December 9th. They set a “buy” rating and a $265.00 target price on the stock. Finally, Rothschild & Co Redburn reissued a “neutral” rating and set a $220.00 price target (down from $245.00) on shares of Danaher in a research note on Wednesday, October 8th. Twenty-one research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $250.96.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.